JY
OM icon

Jeff Yass’s Outset Medical OM Stock Holding History

Jeff Yass’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
47,500
+34,700
+271% +$152K ﹤0.01% 11897
2026
Q1 		$49.2K Buy
+12,800
New +$52.5K ﹤0.01% 12639
2025
Q3 		– Sell
-19,200
Closed -$369K – 13472
2025
Q2 		$369K Sell
19,200
-65,900
-77% -$1.03M ﹤0.01% 9877
2025
Q1 		$941K Buy
85,100
+82,767
+3,548% +$987K ﹤0.01% 7406
2024
Q4 		$38.9K Buy
2,333
+960
+70% +$12K ﹤0.01% 11771
2024
Q3 		$14K Buy
+1,373
New +$40.8K ﹤0.01% 11685
2024
Q1 		– Sell
-2,020
Closed -$164K – 12997
2023
Q4 		$164K Buy
+2,020
New +$164K ﹤0.01% 10886
2022
Q4 		– Sell
-907
Closed -$217K – 13311
2022
Q3 		$217K Sell
907
-373
-29% -$99.9K ﹤0.01% 10626
2022
Q2 		$285K Sell
1,280
-640
-33% -$275K ﹤0.01% 9705
2022
Q1 		$1.31M Sell
1,920
-567
-23% -$341K ﹤0.01% 6467
2021
Q4 		$1.72M Buy
2,487
+1,020
+70% +$754K ﹤0.01% 5867
2021
Q3 		$1.09M Buy
+1,467
New +$1,000K ﹤0.01% 7333

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Jeff Yass's OM Position: Q2 2026 in Review

Jeff Yass increased its Outset Medical (OM) stake by 191% in Q2 2026, buying an estimated $232K and bringing the position to 81,023 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #10713.

Jeff Yass first reported a position in OM in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.36M in Q2 2023. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Jeff Yass held 81,023 shares of Outset Medical worth $350K as of Q2 2026.
  • Jeff Yass bought 53,143 Outset Medical shares in Q2 2026, an estimated $232K.
  • Outset Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10713 holding.
  • Jeff Yass first reported a position in Outset Medical in Q3 2020 and has held it in 18 quarters since.
  • Jeff Yass's Outset Medical position peaked at $1.36M in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.